Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 39Breast 26Plasma cell 18Lymphoid 13Other hematologic neoplasm 5Genitourinary 4Thoracic 2Sarcoma 2Other solid neoplasm 2Gastrointestinal 2NET 1Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 286Oxaliplatin 274Gemcitabine 222Capecitabine 221Leucovorin 219Bevacizumab 200Irinotecan 170pembrolizumab 140Cisplatin 132Cetuximab 111Radiotherapy 109Sorafenib 75Nivolumab 75130-nm albumin-bound paclitaxel 64Paclitaxel 63Albumin-Bound Paclitaxel 63Docetaxel 61Erlotinib Hydrochloride 57Panitumumab 56Radiosurgery 47Folfox protocol 46regorafenib 45Sunitinib 40Radiation 39Magnetic Resonance Spectroscopy 38durvalumab 33Surgical Procedures, Operative 33Trastuzumab 32Ramucirumab 32Cyclophosphamide 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × liposomal doxorubicin × Gastrointestinal × Clear all
NCT01464593 2022-10-13

ABLATE

Imunon

Phase 2 Terminated
2 enrolled 5 charts
Gastrointestinal

Colonic Neoplasms, Liver Neoplasms

NCT00426127 2017-12-29

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer

University of Iowa

Phase 2 Terminated
2 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡